Transfer of data of SONATA 2 cochlear implant recipients
OtherData from SONATA 2 cochlear implant recipients is transferred to CASTOR EDC
NCT Number: NCT07697911
MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.
However, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.
Trial opening soon.
Get NotifiedAll sexes
Observational
Hospital Universitario La Paz, Madrid, Spain
Data from SONATA 2 CI recipients will be transferred to predefined fields in an electronic data capture system (CASTOR EDC) by the investigators. The data transfer starts after the approval of the Ethics Committees (EC). Data will be included for all subjects who meet the inclusion/exclusion criteria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Data from SONATA 2 cochlear implant recipients is transferred to CASTOR EDC
Time frame: pre-operative to 5 years post-operative
Time frame: pre-operative to 5 years post-operative
Time frame: up to 5 years post-operative
Wearing time in hours of audio processor used together with SONATA 2 cochlear implant
Time frame: up to 5 years post-operative
Descriptive summary of which electrode type and audio processor type was used together with a SONATA 2 cochlear implant
Time frame: pre-operative
descriptive summary of age at implantation, date of implantation, gender, type and duration of hearing loss, indications
Time frame: up to 5 years post-operative
Time frame: pre-operative to 5 years post-operative
Hearing Implant Sound Quality Index (HISQUI19)
Time frame: pre-operative to 5 years post-operative
Speech, Spatial, and Qualities of Hearing Scale (SSQ)
Time frame: pre-operative to 5 years post-operative
Nijmegen Cochlear Implant Questionnaire (NCIQ), LittlEars Auditory Questionnaire (LEAQ), Glasgow Benefit Inventory (GBI)
Time frame: pre-operative to 5 years post-operative
LittlEars Auditory Questionnaire (LEAQ)
Time frame: pre-operative to 5 years post-operative
Glasgow Benefit Inventory (GBI)
Contact information is provided by the study sponsor or research team.
MED-EL Elektromedizinische Geräte GesmbH
Industry
Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study
Acronym: LORIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07678879
Cochlear Implant, Cochlear Implant Listeners
Nashville, Tennessee, United States
View Trial DetailsNCT07297524
Cochlear Implant, Ear Diseases
Seoul, South Korea
View Trial DetailsNCT06914531
Cochlear Implant, Deaf Children
Toulouse, France
View Trial DetailsNCT07703800
Cochlear Implant, Ear Diseases
Antwerp, Belgium
View Trial Details